Apoptosemarker

Apoptosemarker is a biomolecule whose presence, modification, or degradation indicates that a cell is undergoing apoptosis, a controlled form of cell death that plays a key role in development, tissue homeostasis, and response to stress. In research and clinical settings, apoptosis markers are used to detect, quantify, and characterize apoptotic processes, distinguish them from necrosis, and monitor responses to therapies that rely on inducing cell death.

Common examples of apoptosis markers include the externalization of phosphatidylserine on the cell surface detected by annexin V binding (an early event in apoptosis), activation of caspases such as caspase-3 and caspase-7 (measured as cleaved forms or via enzymatic activity), and DNA fragmentation detected by TUNEL assays or analysis of sub-G1 DNA content. Additional markers include cleavage of substrates such as poly(ADP-ribose) polymerase (PARP), release of cytochrome c from mitochondria, and changes in mitochondrial membrane potential. In clinical samples, soluble fragments such as cytokeratin-18 assays (for example, caspase-cleaved K18, M30, and related markers) can reflect epithelial cell apoptosis in blood or plasma.

Detection methods for apoptosis markers span several techniques, including flow cytometry with Annexin V and propidium iodide to distinguish early and late apoptosis, immunohistochemistry or Western blotting for cleaved caspases and PARP, TUNEL staining for DNA breaks, and ELISA or multiplex assays for soluble markers in plasma or serum.

Applications of apoptosis markers include evaluating the effects of anticancer therapies, studying developmental biology and neurodegenerative disease mechanisms, and monitoring immune responses. Limitations include the transient nature of marker expression, overlap with necrotic pathways, and the lack of a single universal marker; therefore, a panel of markers is often used to confirm apoptotic cell death.